Introduction
Losartan is an angiotensin II receptor antagonist drug to be marketed. It is chemically described as a (2-butyl-4-chloro-1-{[2'-(1H-testrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol.
Its empirical formula is C 22 H 23 ClN 6 O , and the chemical structural is shown in fig-I . Losartan is a white crystalline powder with a molecular weight of 422.9. It is orally active non-peptide angiotensin II (Type AT1) receptor antagonists, losartan is indicated for the treatment of hypertension. It may also delay progression of diabetic nephropathy, and is also indicated for the reduction of renal disease progression in patients with type 2 diabetes. [1] [2] [3] [4] The objective of validation of an analytical procedure is to demonstrate that it is suitable for its intended purpose. The intended use of analytical methods is to assess product quality and validation is the process of generating experimental data that provides evidence that the performance of an analytical method is adequate for reliably assessing product quality. [5] [6] [7] [8] Method validation acceptance criteria necessarily reflect what we believe is "adequate performance." The validation procedure has been performed by using ultra performance liquid chromatography. The method has been validated for linearity, precision (system repeatability, method repeatability, and method reproducibility), accuracy, range, specificity, and solution stability. [9] [10] [11] Literature survey indicates that there is no RP-LC short run time method available for assay determination of Losartan, [12] [13] [14] [15] thus we aimed to develop it. Liquid chromatography is a new technique used in analytical chemistry for separating and analyzing substances. Chromatography depends on the distribution of the mixture between two phases, one of them is fixed and is called Stationary phase while the other is not fixed and is called the Mobile phase. The mixture is dissolved in the moving phase and passed over a stationary phase. When a mixture of components is introduced in to a LC column, they travel according to their relative affinities towards the stationary phase. The component which has more affinity towards the adsorbent travels slower. The component which has less affinity towards the stationary phase travels faster. Since no two components have the same affinity towards the stationary phase, the components are separated. [15] [16] [17] [18] [19] 
LC instrumentation and conditions
The analysis of the drug was carried out on a Waters Acquity UPLC (Ultra performance liquid chromatography) Binary Gradient System, 10μL injection loop column with auto injector. Column compartment having temperature control and for detection Ultraviolet Detector was employed throughout the analysis.
Chromatographic conditions
Acquity BEH 1.7µ, (2.1 X 100) mm, Make: Waters, analytical column was used for separation. Column temperature was 40°C. Mobile phase consisted of buffer (Adjust pH 3.0 of water with dilute formic acid) : Acetonitrile (50:50 v/v). Mix well and filter through 0.22μm filter. The mobile phase was prepared freshly and degassed by sonicating for 5min before use. Water : Methanol (90:10 v/v) was used as diluent. The analysis was done on isocratic flow of 0.3ml/min with UV detection wavelength was performed at 230 nm at 15°C temperature using 3.0 μL injection volumes with auto injector.
Stock and working standard solutions
Accurately weigh and transfer 25mg of losartan working standard into a 50mL volumetric flask, add about 30mL of diluent and sonicate to dissolve it completely and make volume up to the mark with the same. Further pipette out 5mL of the above stock solution into a 50mL volumetric flask and dilute up to the mark with diluent. Mix well and filter through 0.22μm filter. Obtain solution concentration was 50μg/ml.
Assay of losartan sample
Accurately weigh and transfer equivalent to 25mg of losartan sample into a 50mL volumetric flask, add about 30mL of diluent and sonicate to dissolve it completely and make volume up to the mark with the same. Further pipette out 5mL of the above stock solution into a 50mL volumetric flask and dilute up to the mark with diluent. Mix well and filter through 0.22μm filter. Obtain solution concentration was 50μg/ml. This solution was injected into LC system. For the determination, Peak area of losartan was measured. Calculate % Losartan by following formulae. 
Method Validation
The objective of the method validation is to demonstrate that the method is suitable for its intended purpose as it is stated in ICH guidelines. The method was validated for linearity, precision (repeatability and intermediate precision), accuracy, specificity, stability and system suitability.
Linearity
The linearity of an analytical procedure is its ability to elicit test results that are directly, or by a well-defined mathematical transformation, proportional to the concentration of analyte in sample within a given range. It should be established initially by visual examination of a plot of signals as a function of analyte concentration of content. If there appears to be a linear relationship, test results should be established by appropriate statistical methods (e.g., by calculation of a regression line by the method of least squares). Five standard solutions of Losartan were prepared from three stocks in the range of 50% to 150 % of the nominal concentration and injected once. Linearity regression analysis demonstrated the acceptability of the method for quantitative determination of Losartan over the concentration range of about 25ppm to 75ppm of the nominal concentration. Linearity graph was shown in fig-2 and slope, intercept correlation factor and Regression equation were shown in table-I.
Precision
The precision of an analytical method is the degree of agreement among individual test results when the method is applied repeatedly to multiple samplings of a homogeneous sample. The precision of an analytical method is usually expressed as the standard deviation or relative standard deviation (coefficient of variation) of a series of measurements. Precision may be a measure of either the degree of reproducibility or repeatability of the analytical method under normal operating conditions. The ICH documents recommend that repeatability should be assessed using a minimum of nine determinations covering the specified range for the procedure (i.e., three concentrations and three replicates of each concentration, or a minimum of six determinations at 100% of the test concentration).
System Repeatability
Standard solution is prepared 50ppm were injected in six times and RSD of areas and retention times were calculated. The percentage RSD of areas was less than 1.0%. Result are presented in 
Accuracy
It is defined as the closeness of test results obtained by the method to the true value. It may often be expressed as percent recovery by the assay of known, added amounts of analyte. Accuracy is a measure of the exactness of the analytical method. The ICH documents recommend that accuracy be assessed using a minimum of nine determinations over a minimum of three concentration levels, covering the specified range (i.e., three concentrations and three replicates of each concentration). The three different concentrations of Losartan standard solutions were determined from three replicate injections, using the linear regression lines (linearity section). 
The average deviations from true value are less than 2.0 %.
Specificity
The ICH documents define specificity as the ability to assess unequivocally the analyte in the presence of components that may be expected to be present, such as impurities, degradation products, and matrix components. In an assay, demonstration of specificity requires that it can be shown that the procedure is unaffected by the presence of impurities or excipients The specificity of the method was verified by testing the blank, standard and sample (un-spiked and spiked), determined the resolution factors between analyte peak (Losartan) and the nearest peak. Sample of Losartan sample spiked with Losartan diamide impurity.
No significant interfering peak appeared in the blank, System suitability and standard chromatogram at the retention times of the analyte peaks.
Range
The range obtained from Linearity, Precision and Accuracy is summarized -ibesartan-25ppm to 75ppm (50% to 150% of nominal sample concentration)
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Conclusion
The finally method developed and validation demonstrated that The Method "Determination of Losartan Assay content by liquid Chromatography as per united state of pharmacopeia (USP) and international conference on harmonisation (ICH) guideline. it is selective, precise, linear, and accurate for performing the determination over the required concentration ranges of 50 to150 % of Losartan nominal sample concentration with very short analysis time that is 3 minutes.
